A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2002
10/03/2002	CA2441092A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/03/2002	CA2441080A1 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/03/2002	CA2440676A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof
10/03/2002	CA2439678A1 Uses of opg ligand to modulate immune responses
10/03/2002	CA2436198A1 Process for obtaining lignan, pharmaceutical compositions and uses thereof
10/02/2002	EP1245583A1 Food product with sustained energy release
10/02/2002	EP1245580A1 Fibre containing composition for enteral nutrition
10/02/2002	EP1245568A1 Sulfonyl derivatives of amino acids and their use as inhibitors of dipeptidyl-peptidase IV (DPP IV)
10/02/2002	EP1245565A1 Indenoindolone derivatives, process for their preparation and pharmaceutical compositions containing them
10/02/2002	EP1245234A1 Procedure for obtaining the different fractions of atomised spanish guava and their use for the treatment of type II diabetes mellitus
10/02/2002	EP1245229A2 Methods and compositions for inhibition of angiogenesis
10/02/2002	EP1244725A2 Amorphous polymeric polyaxial initiators and compliant crystalline copolymers therefrom
10/02/2002	EP1244700A2 Vesicle trafficking proteins
10/02/2002	EP1244683A1 21 human secreted proteins
10/02/2002	EP1244678A1 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b)
10/02/2002	EP1244677A1 Phosphonic acid biaryl derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b)
10/02/2002	EP1244672A1 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors
10/02/2002	EP1244669A1 Pyrazolopyrazines and their use as adenosine antagonists
10/02/2002	EP1244666A1 Imidazopyrimidinyl and imidazopyridinyl derivatives
10/02/2002	EP1244653A1 Non peptide tachykinin receptor antagonists
10/02/2002	EP1244642A1 Substituted oxazoles and thiazoles derivatives as hppar alpha activators
10/02/2002	EP1244626A2 Caspase inhibitors and uses thereof
10/02/2002	EP1244619A1 Pyrrolidines which inhibit camp-specific pde
10/02/2002	EP1244461A2 INHIBITION OF GSK-3$g(b)
10/02/2002	EP1244458A2 Weight promoting composition, method, and product
10/02/2002	EP1244457A2 Methods and compositions related to modulators of annexin and cartilage homeostasis
10/02/2002	EP1244454A2 Use of 2-amino-3,4-dihydro-quinazolines for producing a medicament for treating or preventing diseases caused by ischaemic conditions
10/02/2002	EP1244452A1 Urotensin-ii receptor antagonists
10/02/2002	EP1244434A2 Use of chemotherapeutic agents
10/02/2002	EP1244433A2 Inhibitors of the inositol polyphosphate 5-phosphatase ship2 molecule
10/02/2002	EP1123103B1 A process for producing an iron-dextran compound
10/02/2002	EP0600930B1 Diagnosis and treatment of autoimmune diseases
10/02/2002	DE10115945A1 Substituierte 2-Carba-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung Substituted 2-carba-3,5-dicyano-4-aryl-6-aminopyridines and their use
10/02/2002	DE10112925A1 Verwendung von Zuckerphosphaten, Zuckerphosphatanalogen, Aminosäuren, Aminosäureanalogen zur Modulation von Transaminasen und/oder der Assoziation p36/Malat Dehydrogenase Use of sugar phosphates, sugar phosphate analogs, amino acids, amino acid analogues for the modulation of transaminases and / or association of p36 / malate dehydrogenase
10/02/2002	DE10112825A1 HESylierung von Wirkstoffen in wässriger Lösung HESylation of drugs in aqueous solution
10/02/2002	CN1372570A Modified exendin and exendin agonists
10/02/2002	CN1372569A Keratinocyte growth factor-2
10/02/2002	CN1372562A Imidazoimidazoles and triazoles as anti-inflammatory agents
10/02/2002	CN1372547A Aminoalkoxy carbazoles for the treatment of CNS diseases
10/02/2002	CN1372544A 新颖的维生素d类似物 Novel analogues of vitamin d
10/02/2002	CN1372543A new vitamin derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments
10/02/2002	CN1372541A Sulfonyl carboxamide derivatives, method for their production and their use as medicaments
10/02/2002	CN1372472A Pernasally absorbable insulin preparations
10/02/2002	CN1372470A Remedies for diabetes
10/02/2002	CN1371920A Persimmon leaf polysaccharide and biological activity thereof
10/02/2002	CN1371746A Chinese medicine composition with functions of regulating blood-liquid and curing chemical liver injury
10/02/2002	CN1371742A Health-care fat-reducing liquid for supplying nutrition in fat-reducing period and use method thereof
10/02/2002	CN1371735A Phospholipid capsule compsotiion with effective blood-lipid regulation function
10/02/2002	CN1371724A Medicine for treating diabetes
10/02/2002	CN1371718A Chinese mediicne for treating diabetes
10/02/2002	CN1091604C Processed ginseng extract having enhanced pharmacological offset and preparation method
10/02/2002	CN1091598C Pharmaceutical use of benzothiophene
10/01/2002	US6459003 Ether compounds
10/01/2002	US6458998 Naphthaleneureas as antidiabetic agents
10/01/2002	US6458851 Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications
10/01/2002	US6458850 Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
10/01/2002	US6458846 Ion channel modulating agents
10/01/2002	US6458845 Macrophage scavenger receptor antagonists
10/01/2002	US6458827 Adjustent of conformation equilibrium; active materials
10/01/2002	US6458822 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
10/01/2002	US6458819 Thiazolium compounds and treatments of disorders associated with protein aging
10/01/2002	US6458817 Aromatic substituted sufure or sulfoxide or sulfone derivatives containing seconday amine and hydroxy groups are useful in treatng metabolic disorders mediated by insulin resistance or hyperglycemia in mammals
10/01/2002	US6458813 2-cyclohexyloxy-5-(2-chlorophenylcarbonylamino)pyridine, for example; treating inflammation, pain, diabetes, cancer
10/01/2002	US6458790 Substituted piperidines as melanocortin receptor agonists
10/01/2002	US6458787 Novel pyrrolidine compounds that are potent and selective inhibitors of pde4, as well as methods of making the same, are disclosed. use of the compounds in the treatment of inflammatory diseases and other diseases involving elevated
10/01/2002	US6458782 Treatments of diabetes and complications of diabetes.
10/01/2002	US6458764 GRF analogs with increased biological potency
10/01/2002	US6458586 Replication of defective vectors with mutations and deletions; gene therapy, vaccines, genetic engineering
10/01/2002	US6458579 For use in investigation, diagnosis and treatment of subjects suspected of or suffering from sulphamidase deficiency
10/01/2002	US6458383 Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
10/01/2002	US6458361 Soaking in water, heating beyond boiling point, stirring, filtering
10/01/2002	US6458351 Yeast extracts
10/01/2002	CA2272719C Apo b-secretion/mtp inhibitory amides
10/01/2002	CA2235943C Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
10/01/2002	CA2168113C Therapeutic peptide derivatives
09/2002
09/30/2002	CA2379791A1 Novel triazine compounds useful as sorbitol dehydrogenase inhibitors
09/30/2002	CA2379203A1 Food with extended energy release
09/27/2002	CA2378876A1 Cyclohexylamine derivatives as subtype selective n-methyl-d-aspartate antagonists
09/26/2002	WO2002074913A2 Nucleic acid-associated proteins
09/26/2002	WO2002074835A1 Process for producing lactic acid oligomer
09/26/2002	WO2002074808A2 Modified insulin with reduced immunogenicity
09/26/2002	WO2002074805A1 Soluble rage protein
09/26/2002	WO2002074792A1 Fo-6979 substances and process for producing the same
09/26/2002	WO2002074780A1 Chemical compounds
09/26/2002	WO2002074770A1 Triazaspiro[5.5]undecane derivatives and drugs containing the same as the active ingredient
09/26/2002	WO2002074768A1 Piperazine derivatives, their preparation and uses in therapy (5ht1b receptor activity)
09/26/2002	WO2002074758A2 Novel amines as histamine-3 receptor ligands and their therapeutic applications
09/26/2002	WO2002074752A1 Metalloproteinase inhibitors
09/26/2002	WO2002074750A1 Metalloproteinase inhibitors
09/26/2002	WO2002074749A1 Metalloproteinase inhibitors
09/26/2002	WO2002074740A1 Biguanide derivatives
09/26/2002	WO2002074730A1 INHIBITORS OF INTEGRIN αvβ¿6?
09/26/2002	WO2002074725A1 Novel ligands of nuclear receptor superfamily, process for producing the same and use thereof
09/26/2002	WO2002074343A2 The use of non-digestible polymeric foams to sequester ingested materials, thereby inhibiting their absorption by the body
09/26/2002	WO2002074326A2 Urocortin-iii and uses thereof
09/26/2002	WO2002074323A2 Using neural thread proteins to treat tumors and other hyperproliferative disorders
09/26/2002	WO2002074319A1 Pharmaceutical formulation and the use thereof for preparing a medicament for the treatment of cardiovascular diseases
09/26/2002	WO2002074318A1 Il-12 expression controlling agents
09/26/2002	WO2002074312A1 Pyrazolo`4,3-d.pyrimidinone compounds as cgmp pde inhibitors
09/26/2002	WO2002074298A1 Il-6 production inhibitors

1 ... 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 ... 1298